The differences in clinical and dermoscopic features between in situ and invasive nevus-associated melanomas and de novo melanomas.


Journal

Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037

Informations de publication

Date de publication:
May 2021
Historique:
received: 29 09 2020
accepted: 14 01 2021
pubmed: 29 1 2021
medline: 15 5 2021
entrez: 28 1 2021
Statut: ppublish

Résumé

Nevus-associated melanomas (NAM) account for 30% of all melanomas and are associated with younger age and with thinner Breslow thickness. Previous studies of NAM dermoscopy found conflicting results. To compare the clinical and dermoscopic features of NAM and de novo melanomas (DNM), stratified by melanoma thickness, in a relatively large cohort of patients. A cross-sectional study of all melanomas biopsied between 2004 and 2019 at a large cancer centre. Lesions were categorized as in situ and invasive NAM or DNM. Dermoscopic images were reviewed and annotated. Associations between melanoma subtype and dermoscopic features were analysed via logistic regression modelling. Bivariate analyses were conducted using non-parametric bootstrap and chi-squared methods. The study included 160 NAM (86 in situ and 74 invasive) and 218 DNM (109 in situ and 109 invasive). NAM were associated with younger age, greater likelihood of being present on the torso, and thinner Breslow thickness. NAM were 2.5 times more likely to show a negative pigment network than DNM. In situ NAM were 2.1 and two times more likely to display dermoscopic area without definable structures and tan structureless areas than DNM, respectively. In situ melanomas were more likely to present a pigment network, and invasive melanomas more commonly presented scar-like depigmentation and shiny white structures. Streaks, blotches and shiny white structures were associated with deeper Breslow depth. Even though the nevus component of NAM could not be identified dermoscopically in the current series, negative pigment network, tan structureless areas and areas without definable structures are dermoscopic clues for NAM.

Sections du résumé

BACKGROUND BACKGROUND
Nevus-associated melanomas (NAM) account for 30% of all melanomas and are associated with younger age and with thinner Breslow thickness. Previous studies of NAM dermoscopy found conflicting results.
OBJECTIVE OBJECTIVE
To compare the clinical and dermoscopic features of NAM and de novo melanomas (DNM), stratified by melanoma thickness, in a relatively large cohort of patients.
METHODS METHODS
A cross-sectional study of all melanomas biopsied between 2004 and 2019 at a large cancer centre. Lesions were categorized as in situ and invasive NAM or DNM. Dermoscopic images were reviewed and annotated. Associations between melanoma subtype and dermoscopic features were analysed via logistic regression modelling. Bivariate analyses were conducted using non-parametric bootstrap and chi-squared methods.
RESULTS RESULTS
The study included 160 NAM (86 in situ and 74 invasive) and 218 DNM (109 in situ and 109 invasive). NAM were associated with younger age, greater likelihood of being present on the torso, and thinner Breslow thickness. NAM were 2.5 times more likely to show a negative pigment network than DNM. In situ NAM were 2.1 and two times more likely to display dermoscopic area without definable structures and tan structureless areas than DNM, respectively. In situ melanomas were more likely to present a pigment network, and invasive melanomas more commonly presented scar-like depigmentation and shiny white structures. Streaks, blotches and shiny white structures were associated with deeper Breslow depth.
CONCLUSIONS CONCLUSIONS
Even though the nevus component of NAM could not be identified dermoscopically in the current series, negative pigment network, tan structureless areas and areas without definable structures are dermoscopic clues for NAM.

Identifiants

pubmed: 33506523
doi: 10.1111/jdv.17133
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1111-1118

Informations de copyright

© 2021 European Academy of Dermatology and Venereology.

Références

Pampena R, Kyrgidis A, Lallas A, Moscarella E, Argenziano G, Longo C. A meta-analysis of nevus-associated melanoma: prevalence and practical implications. J Am Acad Dermatol 2017; 77: 938-945.e4.
Shain AH, Yeh I, Kovalyshyn I et al. The genetic evolution of melanoma from precursor lesions. N Engl J Med 2015; 373: 1926-1936.
Pampena R, Manfreda V, Kyrgidis A et al. Digital dermoscopic changes during follow-up of de-novo and nevus-associated melanoma: a cohort study. Int J Dermatol 2020; 59: 813-821.
Alendar T, Kittler H. Morphologic characteristics of nevi associated with melanoma: a clinical, dermatoscopic and histopathologic analysis. Dermatol Pract Concept 2018; 8: 104-108.
Manrique-Silva E, Reyes-García D, Folgado B et al. The proportion of nevus-associated invasive melanoma differs with Breslow thickness: a cross-sectional study of 1087 cutaneous melanomas. J Am Acad Dermatol 2019; 81: 852-854.
Stante M, Carli P, Massi D, De Giorgi V. Dermoscopic features of naevus-associated melanoma. Clin Exp Dermatol 2003; 28: 476-480.
Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995; 33: 1000-1007.
Kaddu S, Smolle J, Zenahlik P, Hofmann-Wellenhof R, Kerl H. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis. Melanoma Res 2002; 12: 271-278.
Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Delfino M. Clinical and dermatoscopic criteria for the preoperative evaluation of cutaneous melanoma thickness. J Am Acad Dermatol 1999; 40: 61-68.
Stante M, De Giorgi V, Cappugi P, Giannotti B, Carli P. Non-invasive analysis of melanoma thickness by means of dermoscopy: a retrospective study. Melanoma Res 2001; 11: 147-152.
Lorentzen HF, Weismann K, Grønhøj LF. Dermatoscopic prediction of melanoma thickness using latent trait analysis and likelihood ratios. Acta Derm Venereol 2001; 81: 38-41.
Balagula Y, Braun RP, Rabinovitz HS et al. The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions. J Am Acad Dermatol 2012; 67: 194.e1-194.e8.
Lallas A, Longo C, Manfredini M et al. Accuracy of dermoscopic criteria for the diagnosis of melanoma in situ. JAMA Dermatol 2018; 154: 414-419.
da Silva VPM, Ikino JK, Sens MM, Nunes DH, Di Giunta G. Dermoscopic features of thin melanomas: a comparative study of melanoma in situ and invasive melanomas smaller than or equal to 1mm. An Bras Dermatol 2013; 88: 712-717.
Shitara D, Nascimento M, Ishioka P et al. Dermoscopy of naevus-associated melanomas. Acta Derm Venereol 2015; 95: 671-675.
Pampín-Franco A, Gamo-Villegas R, Floristán-Muruzábal U et al. Nevus-associated melanoma: an observational retrospective study of 22 patients evaluated with dermoscopy and reflectance confocal microscopy. Ski Res Technol 2020; 26: 99-104.
Zalaudek I, Conforti C, Guarneri F et al. Clinical and dermoscopic characteristics of congenital and noncongenital nevus-associated melanomas. J Am Acad Dermatol 2020; 83: 1080-1087.
Gallus S, Naldi L, Carli P et al. Nevus count on specific anatomic sites as a predictor of total body count: a survey of 3,406 children from Italy. Am J Epidemiol 2007; 166: 472-478.
Farnetani F, Scope A, Mazzoni L et al. A comparative dermoscopic and reflectance confocal microscopy study of naevi and melanoma with negative pigment network. J Eur Acad Dermatology Venereol 2019; 33: 2273-2282.
Yadav S, Vossaert KA, Kopf AW, Silverman M, Grin-Jorgensen C. Histopathologic correlates of structures seen on dermoscopy (epiluminescence microscopy). Am J Dermatopathol 1993; 15: 297-305.
Scope A, Zalaudek I, Ferrara G, Argenziano G, Braun RP, Marghoob AA. Remodeling of the dermoepidermal junction in superficial spreading melanoma. Arch Dermatol 2008; 144: 1644-1649.
Massi D, De Giorgi V, Soyer HP. Histopathologic correlates of dermoscopic criteria. Dermatol Clin 2001; 19: 259-268.

Auteurs

O Reiter (O)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Dermatology, Rabin Medical Center, Petah Tikvah and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

N Kurtansky (N)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

J K Nanda (JK)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

K J Busam (KJ)

Pathology Department, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

A Scope (A)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Dermatology, Rabin Medical Center, Petah Tikvah and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

S Musthaq (S)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

A A Marghoob (AA)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH